Formulation and development of industry feasible proniosomal transdermal drug delivery system of granisetron hydrochloride. AJP [Internet]. 2015 Apr. 17 [cited 2026 Apr. 15];9(2):113-9. Available from: https://www.asiapharmaceutics.info/index.php/ajp/article/view/440